Mylan’s NHK-Fintiv challenge denied by SCOTUS
20-01-2022
Supreme Court denies MS treatment patent petition
25-03-2021
Biogen loses another battle over MS drug patent
21-09-2020
EPO revokes Copaxone patent, clears path for Mylan
17-09-2020
Mylan launches Tecfidera generic amid Biogen battle
20-08-2020
Australian court affirms Mylan patent invalidation
06-07-2020
English appeals court refuses Neurim injunction for insomnia drug
26-06-2020
Biogen blocking bid rejected; signs $2.4bn deal
28-02-2020
Biogen fights off Mylan’s Tecfidera patent challenge
06-02-2020